The main difference between a clinical trial and an expanded access program is that the intention of a clinical trial is to conduct research to test safety and efficacy of a new drug, while the intention of an expanded access program is for a physician to provide treatment to their patient with an unmet medical need. Both clinical trials and expanded access programs have eligibility criteria to determine who can participate.
However, the criteria of expanded access programs usually allow for a broader group of patients. This means that a patient who is not eligible for a clinical trial might be able to access a new drug via an expanded access program. Patients who enroll in expanded access programs are often the sickest patients who have exhausted other treatment options.
sysadmin@impactmedia.co.uk
26 Feb 2025
6 mins read
myTomorrows Team
5 Jun 2024
3 mins read
myTomorrows Team
24 Apr 2024
8 mins read
myTomorrows Team
4 Apr 2024
4 mins read
myTomorrows Team
18 Mar 2024
3 mins read
myTomorrows Team
14 Mar 2024
4 mins read
myTomorrows Team
2 Feb 2024
13 mins read
myTomorrows Team
18 Jan 2024
13 mins read
myTomorrows Team
30 Nov 2023
10 mins read
myTomorrows Team
13 Sep 2023
2 mins read